Henry Schein Medical Supports Healthcare Professionals During Diabetes Awareness Month

November marks American Diabetes Month®, an important time to raise awareness about diabetes and support the 1.2 million new diabetes diagnoses in the U.S. each year, along with the more than 38 million Americans living with the disease. To help healthcare professionals enhance care and improve patient outcomes, Henry Schein is offering a comprehensive range of diabetes management solutions.

Henry Schein Medical’s diabetes care products include:

  • Capital Equipment: Baxter RetinaVue™ 700 Imager and Midmark steam sterilizers and chairs.
  • Point of Care Diagnostics: Abbott Afinion™ 2 analyzer, Piccolo Xpress analyzers, HemoCue® Glucose 201 and Hb 801 Systems, Henry Schein TRUE METRIX Pro Blood Glucose Meter Kit, OneStep+ Pro Hb Analyzer, PTS Diagnostics A1CNow, CardioChek®, Siemens DCA Vantage analyzer, and Vidan Diagnostics Lucidplus™ B-Ketone Plus Blood Glucose Monitoring System.
  • Laboratory: Beckman Coulter, Horiba, Siemens chemistry and immunoassay analyzers, Tosoh Bioscience immunoassay analyzers, and Sysmex hematology analyzers.
  • Hypodermics and Blood Collection: Embecta products and Sol-Millennium lancets.
  • Pharmaceuticals: Over-the-counter medications and prescription medications.

“At Henry Schein, we understand the critical role healthcare professionals play in managing diabetes and improving patients’ quality of life,” said Stephanie Shen, Chief Product Officer for Henry Schein’s North America Distribution Group. “Our goal is to provide practitioners with a comprehensive range of tools, from point-of-care diagnostics to remote patient monitoring, all in one place. We’re proud to work with our supplier partners to enhance the delivery of diabetes care.”

Remote Patient Monitoring with Rimidi

In addition to traditional diabetes care products, Henry Schein offers Rimidi, a remote patient monitoring solution. Rimidi connects patient-generated data from blood glucose monitors, continuous glucose monitors, and insulin pens with clinical data in electronic health record (EHR) systems. This integration provides clinicians with a more complete picture of a patient’s health, offering insights that support individualized care, based on the latest evidence and clinical guidelines. The platform works seamlessly within the EHR system, streamlining workflow for providers.

Henry Schein Cares Foundation: Prevention is Power™

This year, Henry Schein Cares Foundation, Inc. (HSCF) launched its Prevention is Power™ campaign, focused on promoting preventive healthcare and integrated care models to improve overall health outcomes. As part of this program, Henry Schein is providing healthcare practitioners with tools to highlight the connection between oral health and overall health, with a special focus on diabetes and oral health.

About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a global solutions company for healthcare professionals, offering a network of people, technology, and products to help improve operational efficiency and clinical outcomes. With a global workforce of approximately 26,000 Team Schein Members, the company supports more than 1 million customers worldwide with over 300 trusted solutions. Henry Schein provides products and services to office-based healthcare practitioners, dental laboratories, government health clinics, and other care providers.

Headquartered in Melville, N.Y., Henry Schein operates in 33 countries and territories and generated $12.3 billion in sales in 2023.

Source link

Newsletter Updates

Enter your email address below and subscribe to our newsletter